Detalhe da pesquisa
1.
Comorbidity and mortality in systemic sclerosis and matched controls: Impact of interstitial lung disease. A population based cohort study based on health registry data.
Chron Respir Dis
; 20: 14799731231195041, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37596992
2.
Direct and indirect costs of systemic sclerosis and associated interstitial lung disease: A nationwide population-based cohort study.
Respirology
; 27(5): 341-349, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35224821
3.
Incidence, prevalence and regional distribution of systemic sclerosis and related interstitial lung Disease: A nationwide retrospective cohort study.
Chron Respir Dis
; 19: 14799731221125559, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36123773
4.
[Methotrexate may be a useful corticosteroid reducing treatment of severe asthma]. / Methotrexat kan anvendes som steroidbesparendebehandling af svær astma.
Ugeskr Laeger
; 177(24): 1159-63, 2015 Jun 08.
Artigo
em Dinamarquês
| MEDLINE | ID: mdl-26554054
5.
[Methotrexate may be a useful corticosteroid reducing treatment of severe asthma].
Ugeskr Laeger
; 176(15)2014 Apr 07.
Artigo
em Dinamarquês
| MEDLINE | ID: mdl-25350142
6.
Methotrexate as an oral corticosteroid-sparing agent in severe asthma: the emergence of a responder asthma endotype.
Eur Clin Respir J
; 12014.
Artigo
em Inglês
| MEDLINE | ID: mdl-26557239
7.
Increasing awareness of corticosteroid hypersensitivity reactions is important.
Respirol Case Rep
; 1(2): 43-5, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25473540